Home | 2 Minute Medicine
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting.
All | 2 Minute Medicine
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting.
Nivolumab+AVD improves progression-free survival in advanced …
2 天之前 · 1. This randomized controlled trial found that in patients with newly diagnosed stage III or IV Hodgkin lymphoma, treatment with nivolumab + AVD (N+AVD) led to longer progression-free survival compared to brentuximab vedotin + AVD (BV+AVD). 2. N+AVD treatment resulted in fewer high-grade adverse events compared to BV+AVD, except neutropenia.
2 Minute Medicine | Concise. Curated. Medical News.
2 Minute Medicine® was created in 2012 by Marc D. Succi, MD, a physician at Harvard Medical School and Massachusetts General Hospital, to fill the need for professional curation and accurate reporting of the medical literature milieu.
Landmark Trials & Summaries: The Classics in Medicine - 2 Minute …
Title Year Journal Citations Key findings; The UKPDS: Reducing the risk of diabetes-related morbidity and mortality: 1998: Lancet: 20,000: 1. For patients with type 2 diabetes mellitus, pharmacologic blood glucose control with sulfonylureas or insulin significantly reduces the risk of microvascular complications, but not macrovascular complications
Beta-blocker interruption not noninferior to continuation following ...
2 天之前 · 1. In this randomized controlled trial, among patients with a history of myocardial infarction (MI), interruption of long-term beta-blocker therapy was not found to be noninferior to beta-blocker continuation in preventing death, MI, stroke, and hospitalization for cardiovascular reasons. 2. Interruption of long-term beta-blocker therapy did not improve patient-reported quality of …
Mineralocorticoid receptor antagonists reduce hospitalizations in ...
2024年10月18日 · 1. Cardiovascular death and first heart failure hospitalization was reduced among HFrEF patients compared to HFmrEF and HFpEF patients. 2. Total heart failure hospitalizations were reduced in HFrEF compared to the other groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Mineralocorticoid receptor antagonists (MRAs) reduce hospitalizations and mortality in patients with heart failure ...
Denosumab increases risk of severe hypocalcemia in women with ...
5 天之前 · In-Depth [retrospective cohort]: This target trial emulation aimed to assess the risk of severe hypocalcemia among patients with all stages of CKD, including with CKD-MBD, associated with denosumab, oral bisphosphonates, and IV bisphosphonates. Inclusion criteria included female sex, age 65 years or older, and receiving first-line treatment for osteoporosis, while exclusion criteria included ...
2 Minute Medicine | Concise. Curated. Medical News.
Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents a multi-edition textbook series composed of summaries of the landmark trials spanning all …
Masthead - 2 Minute Medicine
2 Minute Medicine® is an award-winning global medical publishing and syndication company borne out of Harvard Medical School (2012). Founded and run by practicing physicians, 2 Minute Medicine® is unique in its expert reporting standards as well as its proprietary news syndication system. 2 Minute Medicine® has licensed tens of thousands of their expert medical